In vivo studies in transgenic mice have shown that the overexpression of catalase targeted to mitochondria reduces age-associated diseases and increases lifespan (López-Armada et al., 2013; Schriner et al., 2005). This evidence concerns the gene CAT and glycogen storage disease VI.